Drug recall · April 15, 2020
Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprostadil 10mcg/Papaverine 30mg/Phentolamine 1mg/ml lnj Soln, 5 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530
- Lots / codes
Lot #02282020@30, Expires after 04/28/2020
- Quantity
- N/A
- Company
- Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy, Murrieta, CA
- Distribution
- Patient Distribution list includes addresses in the following states: CA, ME, TX
- Initiated
- March 26, 2020 · Voluntary: Firm initiated
- Classified
- April 6, 2020
- Reported
- April 15, 2020
- Ended
- January 29, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.